Slide 1: Owlet, Inc. Q1 2025 Financial Results
Owlet, Inc. (NYSE: OWLT) Q1 2025 Financial Results May 8, 2025 March 4, 2025 1
Slide 2: Conference Call
Owlet, Inc. (NYSE: OWLT) | Q1 2025 Financial Results Conference Call Speakers ● Kurt Workman, CEO and Co-Founder ● Jonathan Harris, President ● Amanda Twede Crawford, CFO ● Jay Gentzkow, VP Investor Relations Webcast ● Domestic Callers: (833) 470-1428 ● International Callers: (404) 975-4839; Access
Slide 3: Disclaimer
Disclaimer Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this press release that do not relate to matters of historical fact should be consid
Slide 4: Owlet Business Update
Owlet Business Update | 4
Slide 5: Owlet Cares Impact: Life Saving Case
Owlet Cares Impact: Life Saving Case "My husband and I originally purchased our Dream Sock for peace of mind. What we didnʼt know is how much this device would actually help us. One night at 1:00am, we received a notification that my sonʼs heart rate was 250-280 bpm, but he did not seem to be in dis
Slide 6: Owlet Business Update | First Quarter 2025
Owlet Business Update | First Quarter 2025 Revenue Gross Margin Adj. EBITDA $21.1M 53.7% $0.0M Growth of 43.1% y/y Expanded 930 bps y/y Improved $3.1M y/y Business Highlights ● Financial performance exceeded expectations across all key metrics ○ Strong 43% y/y revenue growth ○ Eighth consecutive qua
Slide 7: Drive continued adoption of Dream Sock, Owlet360, Pediatric Health
Drive continued adoption Owlet360 Pediatric Health Expand medical + of Dream Sock Subscription healthcare channels Core domestic growth Supporting parents from infancy Insurance reimbursed health + into the toddler years & monitors for high-risk babies International expansion increasing LTV | 7
Slide 8: Financial Highlights
Financial Highlights | 8
Slide 9: Financial Review | Q1 2025
Financial Review | Q1 2025 Revenue Gross Margin ● $21.1M Q1ʼ25 revenue ● 53.7% Q1ʼ25 gross margin ● 43.1% growth y/y ● 930 bps expansion y/y $ in millions | 9
Slide 10: Financial Review | Q1 2025
Financial Review | Q1 2025 Operating Expenses Adj. EBITDA ● $14.0M Q1ʼ25 total operating expenses ● $0.0M Q1ʼ25 adj. EBITDA ● $1.7M increase vs. Q1ʼ24 ● $3.1M improvement vs. Q1ʼ24 $ in millions $ in millions Note: Adjusted EBITDA is defined as net income (loss) adjusted for income tax provision, in
Slide 11: Updating FY 2025 Guidance
Updating FY 2025 Guidance Previous New 2025E Guidance Guidance Revenue $88M – $92M $91M – $95M 17-22% growth y/y Updated for new tariff Gross Margin 50% – 52% 46% – 50% cost impacts Adj. EBITDA Positive Positive Including tariff impacts Note: Adjusted EBITDA is defined as net income (loss) adjusted fo
Slide 12: Q&A
Q&A | 12